Company profile for SeaStar Medical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

SeaStar Medical is a medical technology company that is focusing on redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. SeaStar Medical’s novel technologies rely on science and innovation to provide life-saving solutions to critically ill patients. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflamm...
SeaStar Medical is a medical technology company that is focusing on redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. SeaStar Medical’s novel technologies rely on science and innovation to provide life-saving solutions to critically ill patients. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3513 Brighton Blvd, Ste 410, Denver, CO 80216
Telephone
Telephone
1-844-427-8100
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

BioProcess International US West

Not Confirmed

envelop Contact Supplier

BioProcess International US West

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/03/05/3250133/0/en/SeaStar-Medical-Announces-Completion-of-FDA-Enrollment-Requirement-for-SAVE-Surveillance-Registry-Evaluating-QUELIMMUNE-Safety-for-Pediatric-AKI.html

GLOBENEWSWIRE
05 Mar 2026

https://www.globenewswire.com/news-release/2026/02/09/3234521/0/en/SeaStar-Medical-Announces-Publication-in-Pediatric-Nephrology-of-Positive-Real-World-Experience-for-QUELIMMUNE-SCD-PED-Therapy-in-Pediatric-Acute-Kidney-Injury-AKI.html

GLOBENEWSWIRE
09 Feb 2026

https://www.globenewswire.com/news-release/2026/01/29/3228564/0/en/SeaStar-Medical-to-Present-at-Upcoming-Noble-Capital-Markets-Emerging-Growth-Virtual-Equity-Conference.html

GLOBENEWSWIRE
29 Jan 2026
Seastar Medical Announces 2026 Milestones
Seastar Medical Announces 2026 Milestones

07 Jan 2026

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2026/01/07/3214506/0/en/SeaStar-Medical-Announces-2026-Milestones.html

GLOBENEWSWIRE
07 Jan 2026

https://www.globenewswire.com/news-release/2026/01/06/3213657/0/en/SeaStar-Medical-to-Present-at-Upcoming-Biotech-Showcase-2026-Investor-Conference.html

GLOBENEWSWIRE
06 Jan 2026

https://www.globenewswire.com/news-release/2025/12/23/3210139/0/en/SeaStar-Medical-Announces-1-for-10-Reverse-Split.html

GLOBENEWSWIRE
23 Dec 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty